BIOR

Biora Therapeutics (BIOR)

Biora Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIOR

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/07	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/03	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/03	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/21	05:08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/21	05:06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/20	21:00	GlobeNewswire Inc.	Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/16	05:05	GlobeNewswire Inc.	Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/07	21:00	GlobeNewswire Inc.	Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/06	21:00	GlobeNewswire Inc.	Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/30	21:00	GlobeNewswire Inc.	Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/08	21:00	GlobeNewswire Inc.	Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/04	21:00	GlobeNewswire Inc.	Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/04	05:05	GlobeNewswire Inc.	Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/01	21:00	GlobeNewswire Inc.	Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/27	05:05	GlobeNewswire Inc.	Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/26	20:21	IH Market News	U.S. Index Futures on the Rise, Oil Prices Show Stability	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/18	21:00	GlobeNewswire Inc.	Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/11	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/11	21:00	GlobeNewswire Inc.	Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/26	22:00	GlobeNewswire Inc.	Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/16	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/16	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/15	04:43	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/08	22:00	GlobeNewswire Inc.	Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium	NASDAQ:BIOR	Biora Therapeutics Inc
2024/01/22	22:00	GlobeNewswire Inc.	Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.	NASDAQ:BIOR	Biora Therapeutics Inc
2024/01/17	07:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc